Announce a third immunology program
Delivered after the deadline (8 days after the deadline)
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 10 Feb 2025
- Due
- 31 Dec 2025
- Delivered
- 8 Jan 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Enanta plans to expand its presence in immunology with the introduction of a third program in 2025.”
What we found
Evidence strength A What the grades mean
Enanta announced its third immunology program (MRGPRX2) on January 8, 2026, after the stated 2025 deadline had passed.
-
A ENANTA PHARMACEUTICALS INC - Form 8-K - FY2025 8-K stating the third program was still planned for 2025, not yet delivered.
-
B Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook Company press release announcing the third immunology program (MRGPRX2).
-
B Enanta Fiscal Q4 and Year-End FY2025 Results Company still describing third program as planned for Q4 2025, not yet announced.
-
B Enanta Fiscal Q1 FY2026 Results Confirms third immunology program was announced in January 2026.
Checked 16 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Announce
- Language
- Expected (“expects”, “plans”)
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesGemini (Google) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Enanta Pharmaceuticals Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-ENTA-000415 · Corrections policy